197 related articles for article (PubMed ID: 8820110)
1. Effects of a novel 2,3-oxidosqualene cyclase inhibitor on the regulation of cholesterol biosynthesis in HepG2 cells.
Mark M; Muller P; Maier R; Eisele B
J Lipid Res; 1996 Jan; 37(1):148-58. PubMed ID: 8820110
[TBL] [Abstract][Full Text] [Related]
2. Effects of a 2,3-oxidosqualene-lanosterol cyclase inhibitor 2,3:22,23-dioxidosqualene and 24,25-epoxycholesterol on the regulation of cholesterol biosynthesis in human hepatoma cell line HepG2.
Dollis D; Schuber F
Biochem Pharmacol; 1994 Jul; 48(1):49-57. PubMed ID: 8043030
[TBL] [Abstract][Full Text] [Related]
3. Ro 48-8.071, a new 2,3-oxidosqualene:lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: comparison to simvastatin.
Morand OH; Aebi JD; Dehmlow H; Ji YH; Gains N; Lengsfeld H; Himber J
J Lipid Res; 1997 Feb; 38(2):373-90. PubMed ID: 9162756
[TBL] [Abstract][Full Text] [Related]
4. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M
Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861
[TBL] [Abstract][Full Text] [Related]
5. Potent inhibition of cholesterol biosynthesis in 3T3 fibroblasts by N-[(1,5,9)-trimethyldecyl]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol, a new 2,3-oxidosqualene cyclase inhibitor.
Gerst N; Duriatti A; Schuber F; Taton M; Benveniste P; Rahier A
Biochem Pharmacol; 1988 May; 37(10):1955-64. PubMed ID: 3377803
[TBL] [Abstract][Full Text] [Related]
6. Effect of FR194738, a potent inhibitor of squalene epoxidase, on cholesterol metabolism in HepG2 cells.
Sawada M; Matsuo M; Hagihara H; Tenda N; Nagayoshi A; Okumura H; Washizuka K; Seki J; Goto T
Eur J Pharmacol; 2001 Nov; 431(1):11-6. PubMed ID: 11716837
[TBL] [Abstract][Full Text] [Related]
7. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis.
Alberts AW
Cardiology; 1990; 77 Suppl 4():14-21. PubMed ID: 2073667
[TBL] [Abstract][Full Text] [Related]
8. Effects of a novel 2,3-oxidosqualene cyclase inhibitor on cholesterol biosynthesis and lipid metabolism in vivo.
Eisele B; Budzinski R; Müller P; Maier R; Mark M
J Lipid Res; 1997 Mar; 38(3):564-75. PubMed ID: 9101437
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels and synthesis in syrian hamster C100 cells by the oxidosqualene cyclase inhibitor [4'-(6-allyl-ethyl-amino-hexyloxy)-2'-fluoro-phenyl]-(4-bromophenyl)-me thanone (Ro 48-8071): comparison to simvastatin.
Peffley DM; Gayen AK; Morand OH
Biochem Pharmacol; 1998 Aug; 56(4):439-49. PubMed ID: 9763219
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
11. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
Qin W; Infante J; Wang SR; Infante R
Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cholesterol biosynthesis in Chinese hamster ovary cells by 4,4,10 beta-trimethyl-trans-decal-3 beta-ol. A specific 2,3-oxidosqualene cyclase inhibitor.
Chang TY; Schiavoni ES; McCrae KR; Nelson JA; Spencer TA
J Biol Chem; 1979 Nov; 254(22):11258-63. PubMed ID: 500643
[No Abstract] [Full Text] [Related]
13. Induction of CYP3A by 2,3-oxidosqualene:lanosterol cyclase inhibitors is mediated by an endogenous squalene metabolite in primary cultured rat hepatocytes.
Shenoy SD; Spencer TA; Mercer-Haines NA; Abdolalipour M; Wurster WL; Runge-Morris M; Kocarek TA
Mol Pharmacol; 2004 May; 65(5):1302-12. PubMed ID: 15102959
[TBL] [Abstract][Full Text] [Related]
14. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol biosynthesis by oxylanosterols.
Panini SR; Sexton RC; Gupta AK; Parish EJ; Chitrakorn S; Rudney H
J Lipid Res; 1986 Nov; 27(11):1190-204. PubMed ID: 3559385
[TBL] [Abstract][Full Text] [Related]
15. Tissue-selective acute effects of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase on cholesterol biosynthesis in lens.
Mosley ST; Kalinowski SS; Schafer BL; Tanaka RD
J Lipid Res; 1989 Sep; 30(9):1411-20. PubMed ID: 2513368
[TBL] [Abstract][Full Text] [Related]
16. Effect of a novel squalene epoxidase inhibitor, NB-598, on the regulation of cholesterol metabolism in Hep G2 cells.
Hidaka Y; Hotta H; Nagata Y; Iwasawa Y; Horie M; Kamei T
J Biol Chem; 1991 Jul; 266(20):13171-7. PubMed ID: 1649182
[TBL] [Abstract][Full Text] [Related]
17. Regulation of squalene synthetase in human hepatoma cell line Hep G2 by sterols, and not by mevalonate-derived non-sterols.
Cohen LH; van Miert E; Griffioen M
Biochim Biophys Acta; 1989 Mar; 1002(1):69-73. PubMed ID: 2538145
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of 2,3-oxidosqualene cyclase and sterol biosynthesis by 10- and 19-azasqualene derivatives.
Viola F; Brusa P; Balliano G; Ceruti M; Boutaud O; Schuber F; Cattel L
Biochem Pharmacol; 1995 Sep; 50(6):787-96. PubMed ID: 7575639
[TBL] [Abstract][Full Text] [Related]
19. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by oxysterol by-products of cholesterol biosynthesis. Possible mediators of low density lipoprotein action.
Panini SR; Sexton RC; Rudney H
J Biol Chem; 1984 Jun; 259(12):7767-71. PubMed ID: 6736025
[TBL] [Abstract][Full Text] [Related]
20. [Activities of 3-hydroxyl-3-methylglutaryl-CoA reductase and acetyl-CoA carboxylase and the rate of mevalonic acid, squalene, sterol and fatty acid biosynthesis from [1-14C]acetyl-CoA and [2-14C]malonyl-CoA in rat liver: effects of Triton WR 1339, starvation and cholesterol diet].
Poliakova ED; Dizhe EB; Klimova TA; Denisenko TV; Vasil'eva LE
Biokhimiia; 1981 Feb; 46(2):296-305. PubMed ID: 6113854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
